Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Many substances, including chemicals and metals, can cause skin reactions; careful handling and identification of allergens are crucial to prevent dermatitis.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Different techniques measure hair properties to ensure cosmetic products work.

A thorough initial check-up is essential before sperm banking to ensure the best chance of preserving good quality sperm.

The review found that PRP is the most effective treatment for hair loss with few side effects.

The removed ovarian tumor was a rare type of blood vessel tumor that improved the patient's symptoms and hormone levels after surgery.

High-dose radioactive iodine therapy does not harm fertility in thyroidectomy patients.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

A male with aromatase deficiency improved bone health with estradiol treatment.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Measuring reproductive hormones in brown bear hair could help identify their sex and reproductive state, but better collection methods or lab techniques are needed.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Long-term steroid abuse in athletes causes serious health risks, outweighing any benefits.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.